McKesson’s proactive approach to drug supply constraints: 3 insights

Healthcare supplier McKesson formed a Critical Care Drug Task Force to proactively manage pharmaceutical supply constraints during the pandemic, according to an Oct. 27 announcement.

Advertisement

What you should know:

1. The task force compares the number of COVID-19 cases on local and national levels with customer demand patterns to forecast supply needs for pharmaceutical manufacturers.

2. The strategy was developed in response to pandemic-induced purchasing increases and is intended to help hospital customers remain prepared to treat COVID-19 patients.

3. The cross-functional team will continue meeting indefinitely.

More articles on surgery centers:
The ASC in 2021: 3 expert predictions on cardiology
10 lowest-paying cities for physicians
ASC valuation multiples continue to rise & more — 12 ASC industry notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.